Binh Dinh Pharmaceutical and Medical Equipment JSC - Asset Resilience Ratio
Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has an Asset Resilience Ratio of 15.84% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read DBD total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2025)
This chart shows how Binh Dinh Pharmaceutical and Medical Equipment JSC's Asset Resilience Ratio has changed over time. See Binh Dinh Pharmaceutical and Medical Equ (DBD) shareholders funds for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Binh Dinh Pharmaceutical and Medical Equipment JSC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Binh Dinh Pharmaceutical and Medical Equ market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₫0.00 | 0% |
| Short-term Investments | ₫409.20 Billion | 15.84% |
| Total Liquid Assets | ₫409.20 Billion | 15.84% |
Asset Resilience Insights
- Good Liquidity Position: Binh Dinh Pharmaceutical and Medical Equipment JSC maintains a healthy 15.84% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Binh Dinh Pharmaceutical and Medical Equipment JSC Industry Peers by Asset Resilience Ratio
Compare Binh Dinh Pharmaceutical and Medical Equipment JSC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC |
Drug Manufacturers - Specialty & Generic | 43.05% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867 |
Drug Manufacturers - Specialty & Generic | 1.96% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Guobang Pharma Ltd
SHG:605507 |
Drug Manufacturers - Specialty & Generic | 8.47% |
Annual Asset Resilience Ratio for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)
The table below shows the annual Asset Resilience Ratio data for Binh Dinh Pharmaceutical and Medical Equipment JSC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 15.84% | ₫409.20 Billion ≈ $15.55 Million |
₫2.58 Trillion ≈ $98.18 Million |
+10.34pp |
| 2024-12-31 | 5.50% | ₫124.42 Billion ≈ $4.73 Million |
₫2.26 Trillion ≈ $86.03 Million |
-5.63pp |
| 2023-12-31 | 11.12% | ₫221.19 Billion ≈ $8.40 Million |
₫1.99 Trillion ≈ $75.57 Million |
-0.56pp |
| 2022-12-31 | 11.68% | ₫221.39 Billion ≈ $8.41 Million |
₫1.90 Trillion ≈ $72.03 Million |
+2.75pp |
| 2021-12-31 | 8.93% | ₫139.20 Billion ≈ $5.29 Million |
₫1.56 Trillion ≈ $59.25 Million |
+2.43pp |
| 2020-12-31 | 6.49% | ₫93.34 Billion ≈ $3.55 Million |
₫1.44 Trillion ≈ $54.61 Million |
-- |
About Binh Dinh Pharmaceutical and Medical Equipment JSC
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company manufactures and trades in pharmaceuticals and medical equipment in Vietnam. It offers antibiotics; anticancer drugs; hemodialysis solutions; hepatobiliary drugs; analgesic and antipyretic drugs; drugs for muscles, bones, and joints; antihistamine anti-allergy drugs; ear, eye, nose, and throat drops; cardiovascular drugs; nervous … Read more